Ajanta Pharma is currently trading around the ₹2800 mark, which has acted as a strong resistance zone over the past few months. The stock has tested this level 4 to 5 times, indicating significant supply pressure and trader interest at this price point.
At this stage, Ajanta Pharma stands at a crucial inflection point:
📈 Bullish Scenario:
A clean breakout above ₹2800, especially with volume confirmation, could potentially lead to a 10% upside in the near term, with scope for a 20% rally if momentum sustains.
📉 Bearish Scenario:
However, if the stock fails to break through and faces rejection again, we might see a pullback of around 10%, as traders book profits or short near resistance.
This setup presents a high-reward trade opportunity with a well-defined risk level, making it a good candidate to keep on your watchlist.
Disclaimer:
This post is for educational and informational purposes only. I am not a SEBI-registered investment advisor or research analyst. Please do your own research or consult a certified financial advisor before making any investment decisions.
At this stage, Ajanta Pharma stands at a crucial inflection point:
📈 Bullish Scenario:
A clean breakout above ₹2800, especially with volume confirmation, could potentially lead to a 10% upside in the near term, with scope for a 20% rally if momentum sustains.
📉 Bearish Scenario:
However, if the stock fails to break through and faces rejection again, we might see a pullback of around 10%, as traders book profits or short near resistance.
This setup presents a high-reward trade opportunity with a well-defined risk level, making it a good candidate to keep on your watchlist.
Disclaimer:
This post is for educational and informational purposes only. I am not a SEBI-registered investment advisor or research analyst. Please do your own research or consult a certified financial advisor before making any investment decisions.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.
Aviso legal
As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.